FEBNM

Certificate of Fellowship of the European Board of Nuclear Medicine

Integrated Therapy Case ReasoningEnglish
Exam overview

Practice session

During an FEBNM-style oral case, a patient with metastatic castration-resistant prostate cancer is referred for ^177Lu-PSMA therapy. Baseline PSMA PET shows intense uptake in bone and nodal disease, but also extensive discordant FDG-avid liver lesions with little PSMA uptake. What is the best recommendation to the multidisciplinary team?

Loading your practice session…